Morgan Stanley
YDES

Morgan Stanley’s YD Bio Ltd YDES Stock Holding History

Morgan Stanley’s Portfolio YDES Stock Details YDES Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$360 Sell
160
-63
-28% -$282 ﹤0.01% 7754
2026
Q1 		$1.72K Sell
223
-76
-25% -$734 ﹤0.01% 7355
2025
Q4 		$3.65K Sell
299
-9,958
-97% -$134K ﹤0.01% 7126
2025
Q3 		$200K Buy
+10,257
New +$178K ﹤0.01% 5889

Other funds holding YDES

GWAG
Garrett Wealth Advisory Group Weatherford, Texas $651M AUM 23.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CCMW
Cypress Capital Management (Wyoming) Sheridan, Wyoming $120M AUM 63.01% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $82.7B AUM 28.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley's YDES Position: Q2 2026 in Review

Morgan Stanley reduced its YD Bio Ltd (YDES) stake by 28% in Q2 2026, selling an estimated $282 and leaving 160 shares worth $360. The position accounts for ﹤0.01% of the portfolio, ranked #7754.

Morgan Stanley first reported a position in YDES in Q3 2025 and has held it in 4 quarters since. The position peaked at $200K in Q3 2025. 12 funds tracked by Wall St. Rank hold YDES as of Q2 2026.

  • Morgan Stanley held 160 shares of YD Bio Ltd worth $360 as of Q2 2026.
  • Morgan Stanley sold 63 YD Bio Ltd shares in Q2 2026, an estimated $282.
  • YD Bio Ltd made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #7754 holding.
  • Morgan Stanley first reported a position in YD Bio Ltd in Q3 2025 and has held it in 4 quarters since.
  • Morgan Stanley's YD Bio Ltd position peaked at $200K in Q3 2025.
  • 12 funds tracked by Wall St. Rank held YD Bio Ltd as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.